HeartBeam (NASDAQ:BEATW – Get Free Report) is anticipated to post its results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of ($0.0860) per share and revenue of $0.1470 million for the quarter.
HeartBeam Price Performance
NASDAQ BEATW opened at $0.02 on Thursday. HeartBeam has a 1 year low of $0.02 and a 1 year high of $0.56. The business’s 50-day moving average is $0.04 and its 200 day moving average is $0.10.
HeartBeam Company Profile
HeartBeam, Inc is a clinical-stage medical technology company focused on transforming the diagnosis of acute cardiac events through innovative electrocardiogram (ECG) solutions. The company’s core offering leverages proprietary VectorBEAM™ technology to reconstruct a full 12-lead ECG from a compact, three-lead wearable or handheld device. By enabling rapid acquisition and secure transmission of high-fidelity ECG data, HeartBeam’s approach aims to expedite the detection of myocardial ischemia in out-of-hospital settings.
HeartBeam’s product ecosystem combines hardware, mobile applications, and cloud-based analytics.
Recommended Stories
- Five stocks we like better than HeartBeam
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for HeartBeam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartBeam and related companies with MarketBeat.com's FREE daily email newsletter.
